IntelliCell BioSciences, a regenerative medicine company, is focused on the expanding regenerative medical markets using stromal vascular fraction derived from adult adipose tissue. IntelliCell will initially focus on selling laboratory suites and licensing its technology to doctors for use in their offices for their patients, and is also setting up centers of excellence where doctors can treat their patients. IntelliCell is also starting FDA investigational new drug (IND) clinical trials at major medical centers for clinical indication approval. For more information visit the company’s Web site at www.intellicellbiosciences.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: